(Q42752136)

6 November 2017

title

Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes (English)

1 reference

6 November 2017

0 references

1 reference

1

1 reference

6 November 2017

3

1 reference

6 November 2017

Jean-Luc Martin

4

0 references

Hubert Fiumelli

series ordinal

2

object named as

Hubert Fiumelli

1 reference

6 November 2017

publication date

8 February 2011

1 reference

6 November 2017

number of pages

10

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

6 November 2017

volume

216

1 reference

6 November 2017

issue

1

1 reference

6 November 2017

page(s)

75-84

1 reference

Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability

6 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Signaling between glia and neurons: focus on synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Astrocytes and synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

New approaches to antidepressant drug discovery: beyond monoamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Non-serotonin anti-depressant actions: direct ion channel modulation by SSRIs and the concept of single agent poly-pharmacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Serine 133-phosphorylated CREB induces transcription via a cooperative mechanism that may confer specificity to neurotrophin signals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Reduced volume of orbitofrontal cortex in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Astrocyte glycogen and brain energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Neuroprotective role of monocarboxylate transport during glucose deprivation in slice cultures of rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

The expression of VGF is reduced in leukocytes of depressed patients and it is restored by effective antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Neuroimaging studies of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Mutational and in silico analyses for antidepressant block of astroglial inward-rectifier Kir4.1 channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Requirement for BDNF in activity-dependent survival of cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Lithium upregulates vascular endothelial growth factor in brain endothelial cells and astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Increased levels of glutamate in brains from patients with mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

A comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine: A 19-F MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Antidepressants increase glial cell line-derived neurotrophic factor production through monoamine-independent activation of protein tyrosine kinase and extracellular signal-regulated kinase in glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Antidepressant actions of the exercise-regulated gene VGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Vascular endothelial growth factor stimulates neurite outgrowth from cerebral cortical neurons via Rho kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Vascular endothelial growth factor promotes neurite maturation in primary CNS neuronal cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Physiology of the neurotrophins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

VGF, a new player in antidepressant action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Antidepressant treatments induce the expression of basic fibroblast growth factor in cortical and hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Pyruvate and lactate protect striatal neurons against N-methyl-D-aspartate-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Neurotrophin regulation of cortical dendritic growth requires activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Neurotrophins regulate dendritic growth in developing visual cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Glial reduction in the subgenual prefrontal cortex in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Activity-dependent regulation of energy metabolism by astrocytes: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Tripartite synapses: astrocytes process and control synaptic information

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Gliogenesis and glial pathology in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Astroglial metabolic networks sustain hippocampal synaptic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

VGF: a novel role for this neuronal and neuroendocrine polypeptide in the regulation of energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Glia are the main source of lactate utilized by neurons for recovery of function posthypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Neuroimaging studies of mood disorder effects on the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Functional significance of brain glycogen in sustaining glutamatergic neurotransmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

New roles for astrocytes: regulation of CNS synaptogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Neuropeptides in depression: role of VGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Antidepressant-like effects of intracerebroventricular FGF2 in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

VEGF as a potential target for therapeutic intervention in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

From monoamines to genomic targets: a paradigm shift for drug discovery in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2190-Y

Glucocorticoids modulate neurotransmitter-induced glycogen metabolism in cultured cortical astrocytes.

21 January 2018

1 reference

12 December 2020

Functional receptors for vasoactive intestinal polypeptide in cultured astroglia from neonatal rat brain

1 reference

12 December 2020

Brain lactate is an obligatory aerobic energy substrate for functional recovery after hypoxia: further in vitro validation

1 reference

12 December 2020

Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy

1 reference

12 December 2020

Stimulation of glycogenolysis in astrocytes by fluoxetine, an antidepressant acting like 5-HT.

1 reference

12 December 2020

Brain-derived neurotrophic factor-induced gene expression reveals novel actions of VGF in hippocampal synaptic plasticity

1 reference

12 December 2020

Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors.

1 reference

12 December 2020

Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression.

1 reference

12 December 2020

Vascular Endothelial Growth Factor Directly Inhibits Primitive Neural Stem Cell Survival But Promotes Definitive Neural Stem Cell Survival

1 reference

12 December 2020

Autocrine-paracrine regulation of hippocampal neuron survival by IGF-1 and the neurotrophins BDNF, NT-3 and NT-4

1 reference

12 December 2020

Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication

1 reference

12 December 2020

Case history: the discovery of fluoxetine hydrochloride (Prozac)

1 reference

12 December 2020

Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments.

1 reference

12 December 2020

Neurotrophic effects of vascular endothelial growth factor on organotypic cortical explants and primary cortical neurons.

1 reference

12 December 2020

The astrocyte odyssey

1 reference

12 December 2020

10.1007/S00213-011-2190-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

6 November 2017

1032888760

0 references

1 reference